'Stronger prices, volume for stocks dual-listed on TASE'

According to a survey carried out by the Israel Securities Authority among 30 of the 100 Israeli companies listed on Nasdaq that dual-listed, identified two unique characteristics for the advantage.

By SHARON WROBEL
January 11, 2007 07:23
1 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Since the introduction of the dual-listing law in Israel in 2000, the share price of Israeli companies dual-listing on both Nasdaq and the local market leaped by 8.5 percent on average, while volume of trade rose by 97%, following a dual-listing on the Tel Aviv Stock Exchange. According to a survey carried out the Israel Securities Authority among 30 of the 100 Israeli companies listed on Nasdaq that dual-listed, identified two unique characteristics for the advantage. On the one hand, it said, the companies did their first public offering in foreign markets followed by a dual-listing on the local market and not vice versa as is common in global capital markets. Secondly, it said, the companies wishing to dual-list on the TASE enjoyed the simple requirement of a listing application and approval by the TASE, while being exempt from any other approvals and listing fees generally levied by other exchanges. With the dual-listing law, companies traded on US markets are able to do a second listing on the TASE with no additional regulatory requirements. The process saves these companies the costs of reporting to two different regulatory systems. In addition, the TASE decided to exempt dual-listed companies from listing rules and fees and maintenance regulations. According to surveys carried out among European managers regarding the benefits of dual-listings in foreign countries, only 60% of those questioned found that the benefits of dual-listings were overriding the costs involved. The main benefit was attributed to the increase in the volume of trade, while at the same time the impact on the share price was negative.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS